Get started
INTUITIVE SURGICAL INC CEDEAR EACH 90 REP 1 ORDII

INTUITIVE SURGICAL INC CEDEAR EACH 90 REP 1 ORD

No trades
See on Supercharts
Overview Financials News
Ideas
Discussions Technicals Seasonals

ISRG trade ideas

Køb af Intuitive SurgicalAbout the Company: Intuitive Surgical Inc. is an American company that is a global leader in robotic-assisted surgery. They are best known for their da Vinci Surgical System, which enables surgeons to perform minimally invasive operations with high precision. Business Model: Intuitive Surgical primarily generates revenue through: Sales of surgical robotic systems (da Vinci platform) Disposable and consumable products (instruments and accessories for procedures) Service contracts (maintenance and support for hospitals and clinics) Technical Analysis: On the monthly chart, the stock is currently testing the 50-day moving average. It remains in a solid upward trend. Looking at the weekly chart, the stock has experienced a 20% correction from the peak, which corresponds to a 61% retracement based on Fibonacci levels. Furthermore, it has held above historical support around 470. If it breaks below this level, the next support is around 360. RSI is currently oversold, indicating a potential buying opportunity. Historically, when RSI was near oversold levels and support was rejected, it provided good entry points. OBV (On-Balance Volume) has shown an upward trend in recent trading days. A rising OBV following an upward price movement typically confirms strong buying interest. Key Metrics: P/E ratio stands at 76, slightly high compared to the industry average. Revenue has increased by 46% since 2021, while EBITDA has grown by nearly 32%. EPS has risen from 4.79 to an expected 6.54, indicating increased shareholder value. Analyst Ratings: Currently, 33 analysts cover Intuitive Surgical: Buy: 22 Hold: 10 Sell: 1 On average, analysts believe Intuitive Surgical should be priced at DKK 626, with a target price range between 350 and 711. This implies an average upside of 27%. Trade Strategy: Entry price: 493 Stop-loss: 450 Take-profit: 600 Risk/reward ratio: 2.62
NASDAQ:ISRGLong
by Aktieideer
1
ISRG in Buy ZoneMy trading plan is very simple. I buy or sell when at three of these events happen: * Price tags the top or bottom of parallel channel zones * Money flow spikes beyond it's Bollinger Bands * Stochastic Momentum Index (SMI) at near oversold overbought level * Price at Fibonacci levels So... Here's why I'm picking this symbol to do the thing. Price in buying zone below bottom of channels Stochastic Momentum Index (SMI) at oversold level Money flow momentum is spiked negative and under at bottom of Bollinger Band Entry at $516.82 Target is upper channel around $593
NLong
by chancethepug
Intuitive Surgical ($ISRG) Set to Release its Financial ResultsThis week, Intuitive Surgical (NASDAQ: NASDAQ:ISRG ) is set to release its financial results, and its stock price is expected to be in the spotlight. The robotics industry giant's product, da Vinci, is utilized by numerous doctors for performing minimally invasive surgeries. Intuitive Surgical's performance has been noteworthy in recent years, with a surge in demand for its product. Consequently, its total revenue increased from $4.47 billion in 2019 to over $7.1 billion in 2023. In the fourth quarter of the previous year, the company reported a 17% increase in revenue to $1.66 billion, with a 22% rise in its instruments and accessories business generating $1.14 billion in revenue. Additionally, the company's revenue from its systems rose to $480 million, with 415 da Vinci surgical systems sold in comparison to 369 in the same period in 2023. This week's earnings report is expected to have a significant impact on the ISRG stock price. Analysts predict that the company's revenue for Q1 will improve from $1.65 billion last year to $1.81 billion. The company's growth is expected to continue, with investors anticipating revenue of $1.98 billion in Q2. The average estimate for the year is that its revenue will reach $8 billion, followed by $9.24 billion in 2026. Intuitive Surgical's ( NASDAQ:ISRG ) strong device sales and recurring revenue, combined with its robust balance sheet, have led analysts to be bullish on the company's prospects. The company has a cash and equivalents balance of more than $7.34 billion and minimal debt. In the last quarter, it generated over $92.6 million in interest income. Recently, Stifel, Citigroup, Mizuho, and Barclays have upgraded the stock, with an average target of $414.80, higher than the current $378.55. The NASDAQ:ISRG shares peaked at $403.97 in March, a 123% increase from its lowest point in 2022. However, the stock has pulled back as some investors took profits while awaiting the financial results. Intuitive Surgical's stock has retested the crucial support level at $370, which was its highest swing in December last year. Typically, a break and retest pattern is a bullish sign in the market. The only potential risk is that it has formed a double-top pattern near $403. The key support and resistance levels to watch are $360 (July 23rd high) and $403, respectively. In conclusion, Intuitive Surgical's financial results this week are anticipated to be a significant factor in determining the company's future stock performance. The company's strong balance sheet, recurring revenue, and robust device sales are among the factors that have led industry analysts to be optimistic about the company's prospects.
N
by DEXWireNews
Intuitive Surgical (ISRG) LongIntuitive Surgical Inc. (ISRG), is the pioneer behind the revolutionary da Vinci Surgical Systems, is transforming the landscape of minimally invasive surgery. With its cutting-edge robotic platforms, ISRG enables precision, efficiency, and enhanced patient outcomes, making it a leader in the medical technology sector. From a market performance perspective, ISRG has delivered impressive returns, demonstrating strong investor confidence. The stock has appreciated **55.45% Year-to-Date, 28.04% in the last 3 months, and a solid 10.94% in the past month. These figures reflect the company's robust financial health, innovation-driven growth, and favorable market sentiment, positioning ISRG as a standout performer in the healthcare sector. Trade Idea: ISRG appears to have completed a corrective ABC wave as the stock bounces off a strong demand zone (~$506–$522).And the stock is likely transitioning into a new impulsive Elliot wave sequence (Wave 1). Trade Setup: Entry: Near $522 (confirmation of demand zone holding). Stop Loss: Below the DZ @ $500.55 (a break invalidates the bullish setup). Take Profit Levels: (Profit Areas projected from the previous Elliott wave): TP1: $579 (~10% gain). TP2: $616 (~18% gain). TP3: $658 (~25% gain). Remmember, “The trend is your friend until it bends at the end.” – Ed Seykota ________________________________________ Disclaimer: This analysis is for educational purposes only and does not constitute financial advice. Trading involves significant risk of loss. Always perform your own analysis and consult a financial advisor before making trading decisions.
NLong
by MESHANL
1
Speculative Madness: The Market’s Bubble Stocks Some stocks areSpeculative Madness: The Market’s Bubble Stocks Some stocks aren't just overvalued—they're in full speculative bubble mode. Fundamentals? Irrelevant. When euphoria takes over, rationality disappears. Here’s my list of bubble stocks that scream unsustainable pricing: SBUX, T, PLTR, BMY, PYPL, NFLX, GS, ISRG, ARM, C, SHOP, BSX, SPOT, UBS, IBKR, RELX, CEG, CRWD, MSTR, MMM, DASH, COF... And let’s not forget the obvious: TSLA, META, AMZN, AVGO, GOOGL, JPM, MA, V, WMT. Honestly, the entire banking sector, brokers, and tech are in bubble territory. What the hell is going on with this market? Why are algos just buying, buying, buying, squeezing all the shorts?! Unbelievable. The dump will be insannnnnnnne!!! 🚨
NShort
by Maximus20000
ISRG Down 2% in Premarket Trading Despite Beating ExpectationsIntuitive Surgical, Inc. (ISRG) experienced a 2% dip in premarket trading on Friday despite reporting robust fourth-quarter earnings that exceeded analysts’ expectations. The medical device company, known for its revolutionary da Vinci surgical robots, continues to showcase its dominance in the minimally invasive surgery market. Here’s a detailed look at the company’s performance, supported by fundamental and technical insights. Strong Financial Performance Intuitive Surgical reported a 25% year-over-year increase in fourth-quarter revenue, reaching $2.41 billion. This figure surpassed the consensus estimate compiled by Visible Alpha, reinforcing the company’s strong growth trajectory. Earnings rose to $686 million, or $1.88 per share, up from $606 million, or $1.69 per share, a year ago. These figures also beat analysts’ expectations, demonstrating the company’s profitability. Operational Highlights Procedure Growth: The number of procedures performed using da Vinci surgical devices increased by 18% year-over-year, signaling strong demand for Intuitive Surgical’s minimally invasive technology. System Installations: The company installed 493 da Vinci systems during the quarter, compared to 415 systems a year earlier. This growth highlights the increasing adoption of its surgical solutions. Future Outlook Intuitive Surgical expects da Vinci procedures to grow by 13% to 16% in 2025. However, the company anticipates a 1 to 2 percentage point decline in its adjusted gross profit margin due to potential new tariffs, which could materially impact its financials. Technical Analysis Despite the strong earnings report, NASDAQ:ISRG shares fell by 2% in premarket trading. The stock’s overbought condition, indicated by an RSI of 75 as of Thursday’s close, suggests a potential for short-term correction. - Gap Down Pattern: Historically, gap-down patterns in NASDAQ:ISRG stock have been filled, hinting at a possible rebound in the coming sessions. This historical behavior aligns with the broader market’s tendency to correct temporary gaps. Key Support and Resistance Levels - Support: Immediate support lies at the 38.2% Fibonacci retracement level, which could act as a cushion in case of further price correction. - Resistance: The pivot point is situated above the 1-month high, presenting a significant barrier for upward momentum. Moving Averages The stock is trading above its 50-day, 100-day, and 200-day moving averages, underscoring its bullish trend in the medium to long term. This alignment of key moving averages strengthens the case for continued upside potential. Market Context - All-Time High: NASDAQ:ISRG shares closed at an all-time high on Thursday, marking a 62% gain over the past year. This performance underscores investor confidence in the company’s long-term prospects. - Sector Strength: The growing adoption of robotic surgical systems positions Intuitive Surgical as a leader in the medical device industry, benefiting from the broader trend toward minimally invasive procedures. Conclusion Intuitive Surgical’s robust financial results and operational milestones underscore its leadership in the surgical robotics market. While the current dip in premarket trading reflects short-term market dynamics, the stock’s strong technical indicators and historical performance suggest a potential rebound. Investors should monitor key support and resistance levels, along with updates on tariff developments, to assess the stock’s trajectory. With a bullish continuation pattern likely in play, NASDAQ:ISRG remains a compelling option for long-term growth-oriented investors.
NLong
by DEXWireNews
Intuitive Surgical, Inc. (ISRG) | Chart & Forecast SummaryKey Indicators on Trade Set Up in General 1. Push Set Up 2. Range Set up 3. Break & Retest Set Up Active Sessions on Relevant Range & Elemented Probabilities; * Asian(Ranging) - London(Upwards) - NYC(Downwards) * Weekend Crypto Session # Trend | Time Frame Conductive | Weekly Time Frame - General Trend - Measurement on Session * Support & Resistance * Trade Area | Focus & Motion Ahead # Position & Risk Reward | Daily Time Frame - Measurement on Session * Retracement | 0.5 & 0.618 * Extension | 0.786 & 1 Conclusion | Trade Plan Execution & Risk Management on Demand; Overall Consensus | Neutral
C
by TradePolitics
ISRG - Smooth FlightOn May 22nd of this year, we identified the beginning of a colossal appreciation in the stock, which we titled "ISRG - Back to the Top. " Today, the alignment and compression of FiboNuvens signal an increased probability that it will continue cruising on this wonderful "Smooth Flight." A 3:1 risk-reward ratio with a short stop-loss point are the attractive features of this operation. If this projection is confirmed and a partial realization occurs at the first target, the stop loss should be moved from its initial position to the same line where the position was opened. This way, the journey towards the final target will proceed with reduced risk of losses and preservation of partial gains achieved so far. Let's see what happens here! Follow us to receive notifications of new trades, as well as frequent updates on ongoing trades. Finally, if you agree with the idea or found it useful, give it a BOOST so it can reach more people!
NLong
by EthosInvest
Intuitive Surgical is Set to Release its Quarterly 2024 ResultsIntuitive Surgical is set to release its Quarterly 2024 results, highlighting its significant impact on the healthcare industry. The company's innovative robotic systems have transformed surgery, leading to a remarkable 22,000% increase in stock price over its lifetime. Now an industry giant with a market capitalization of $161 billion, questions about Intuitive Surgical's long-term growth and stock investment potential abound. Intuitive Surgical, founded in the mid-1990s, provides robotic systems that enhance minimally invasive surgeries, helping surgeons reduce errors, improve mobility, and achieve better patient outcomes with smaller incisions. Over 60,000 surgeons have trained on its da Vinci system, and as of Q2 2024, the company has over 9,800 installed systems, with a 14% year-over-year growth in installations. Investors value two main aspects of Intuitive Surgical's business: the reliance on system maintenance, which has increased recurring revenue from 71% in 2016 to 83% last year, making cash flow more predictable, and substantial growth potential outside the U.S., with only 3,818 of an estimated 165,000 global hospital sites currently using their systems. However, the stock's substantial rise poses concerns about whether this growth is already accounted for in its valuation. Over the past decade, Intuitive Surgical shares ( NASDAQ:ISRG ) have appreciated nearly 800%, resulting in heightened market expectations that may lead to a difficult reset if future results fall short. Analysts anticipate average earnings growth of 17% annually over the next three to five years, which may not be sufficient to justify the stock’s forward price-to-earnings (P/E) ratio of 69. With a PEG ratio nearly at 4, this suggests that the stock is overvalued relative to its expected growth. Despite its recent upward trend since November 2023, indicated by a balanced Relative Strength Index (RSI) of 53, the stock is presently deemed too expensive for investors seeking strong returns. Therefore, while Intuitive Surgical ( NASDAQ:ISRG ) shows promising long-term growth potential, it may be wise to consider it as a target for investment when shares drop below current levels.
NLong
by DEXWireNews
Intuitive Surgical (ISRG) Analysis Market Leadership: Intuitive Surgical NASDAQ:ISRG , the leader in robotic-assisted surgery with its da Vinci system, is poised for substantial growth. The increasing adoption of robotic surgeries, currently under 5% of potential procedures, presents a significant opportunity. Additionally, the aging global population boosts demand for minimally invasive surgeries, favoring Intuitive Surgical's market position. Analyst Projections: Analysts project a median upside of 13% to 25% over the next year. For investors seeking steady returns and a strong healthcare business with a solid competitive moat, ISRG is an excellent choice. Investment Outlook: Bullish Outlook: We are bullish on ISRG above the $350.00-$355.00 range. Upside Potential: With a target set at $540.00-$550.00, key growth drivers include the ongoing adoption of robotic surgeries and favorable demographic trends. 📊🤖 Monitor Intuitive Surgical for promising investment opportunities! #ISRG #RoboticSurgery 📈💼
NLong
by Richtv_official